Abstract:A pH‐responsive polydopamine nanocluster R‐P@PDA‐GC for enhanced phototherapy‐induced pyroptosis and anti‐tumor immunity via a two‐input programmed cascade therapy is rationally designed. This novel two‐input programmed cascade strategy of R‐P@PDA‐GC generated substantial ROS within tumor cells, initiating cell pyroptosis, remodeling the TME and facilitating potent anti‐tumor immunotherapy. Pyroptosis, an inflammatory cell death, plays a pivotal role in activating inflammatory response, reversing immunosuppression and enhancing anti‐tumor immunity. However, challenges remain regarding how to induce pyroptosis efficiently and precisely in tumor cells to amplify anti‐tumor immunotherapy. Herein, a pH‐responsive polydopamine (PDA) nanocluster, perfluorocarbon (PFC)@octo‐arginine (R8)‐1‐Hexadecylamine (He)‐porphyrin (Por)@PDA‐gambogic acid (GA)‐cRGD (R‐P@PDA‐GC), is rationally design to augment phototherapy‐induced pyroptosis and boost anti‐tumor immunity through a two‐input programmed cascade therapy. Briefly, oxygen doner PFC is encapsulated within R8 linked photosensitizer Por and He micelles as the core, followed by incorporation of GA and cRGD peptides modified PDA shell, yielding the ultimate R‐P@PDA‐GC nanoplatforms (NPs). The pH‐responsive NPs effectively alleviate hypoxia by delivering oxygen via PFC and mitigate heat resistance in tumor cells through GA. Upon two‐input programmed irradiation, R‐P@PDA‐GC NPs significantly enhance reactive oxygen species production within tumor cells, triggering pyroptosis via the Caspase‐1/GSDMD pathway and releasing numerous inflammatory factors into the TME. This leads to the maturation of dendritic cells, robust infiltration of cytotoxic CD8+ T and NK cells, and diminution of immune suppressor Treg cells, thereby amplifying anti‐tumor immunity.

Perfluorocarbon-Encapsulated Porphyrin-Lipid Nanoparticles As a Photoactive Pyroptosis Inducer for Cancer Therapy

Reactive Oxygen Species‐Mediated Pyroptosis with the Help of Nanotechnology: Prospects for Cancer Therapy

Pyroptosis Activation by Photodynamic-Boosted Nanocatalytic Medicine Favors Malignancy Recession

Biocompatible conjugated porphyrin nanoparticles with photodynamic/photothermal performances in cancer therapy

Organic Small Molecular Nanoparticles Based on Self-Assembly of Amphiphilic Fluoroporphyrins for Photodynamic and Photothermal Synergistic Cancer Therapy.

Activation of Pyroptosis by Specific Organelle-Targeting Photodynamic Therapy to Amplify Immunogenic Cell Death for Anti-Tumor Immunotherapy

Biodegradable Persistent Luminescence Nanoparticles as Pyroptosis Inducer for High‐Efficiency Tumor Immunotherapy

Cascade Amplification of Pyroptosis and Apoptosis for Cancer Therapy Through a Black Phosphorous-Doped Thermosensitive Hydrogel.

FePd Nanozyme- and SKN-Encapsulated Functional Lipid Nanoparticles for Cancer Nanotherapy via ROS-Boosting Necroptosis

Hypoxia-accelerating pyroptosis nanoinducers for promoting image-guided cancer immunotherapy

Near‐Infrared Light Triggered Thermoresponsive Pyroptosis System for Synergistic Tumor Immunotherapy

Pyroptosis Induction with Nanosonosensitizer‐Augmented Sonodynamic Therapy Combined with PD‐L1 Blockade Boosts Efficacy against Liver Cancer

Peroxidase-like Fe3O4 nanocomposite for activatable reactive oxygen species generation and cancer theranostics

A pyroptosis nanotuner for cancer therapy

Photocatalytic Superoxide Radical Generator that Induces Pyroptosis in Cancer Cells

A Mitochondria‐Targeted Photosensitizer for Combined Pyroptosis and Apoptosis with NIR‐II Fluorescence/Photoacoustic Imaging‐Guided Phototherapy

Biodegradable upconversion nanoparticles induce pyroptosis for cancer immunotherapy

Programmed Cascade Polydopamine Nanoclusters for Pyroptosis‐Based Tumor Immunotherapy

Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy

Perfluorocarbon@Porphyrin Nanoparticles For Tumor Hypoxia Relief To Enhance Photodynamic Therapy Against Liver Metastasis Of Colon Cancer

Copper‐bacteriochlorin Nanosheet as A Specific Pyroptosis Inducer for Robust Tumor Immunotherapy